Therapeutic Rewiring of Colorectal Cancer
REWIRE-CAN plans to reprogramme cancer cells into vulnerable states by disrupting their finely tuned “Goldilocks” state.
The team’s discoveries aim to provide a roadmap for therapeutic rewiring of cancer cells by signalling modulation across tumour types.
What does hyperactivation mean?
The REWIRE-CAN Team
Bart Vanhaesebroeck, Team Lead
UCL Cancer Institute
Bart is a basic scientist with a keen interest in applying newly acquired knowledge to understand and treat human disease. Throughout his research career, he has always been involved in fundamental research that could be applied to drug development.
Thank you to our funders
Team REWIRE-CAN is funded by Cancer Research UK, the National Cancer Institute, the Bowelbabe Fund for Cancer Research UK and Yosemite (oncology-focused venture firm) through Cancer Grand Challenges.
